Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Avapritinib

EU orphan designation number: EU/3/18/2074   
Active ingredient: Avapritinib
Indication: Treatment of mastocytosis
Sponsor: PhaRA bvba
Anneessensstraat 3-5 B9, 2018 Antwerpen, België

  

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/10/2018 Orphan designation EMA/OD/079/18 (2018)7275 of 26/10/2018